Product Information
NUVIGIL 250 MG TABLET is a brand product labeled by Cephalon, LLC, priced at $34.7392 per EA under NDC 63459022530. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on Jun 15, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Cephalon, LLCNDC
63459022530
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
ARMODAFINILApproval Type
New Drug (NDA)
FDA Application
NDA021875FDA Approved
6/15/2007
TE Code
AB
On Market Since
5/26/2009
Price Statistics
The NADAC for NUVIGIL 250 MG TABLET has been published 658 times since Nov 28, 2013, and over the history we have for it it has risen 135.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $34.7392 per EA |
|---|---|
| All-time high | $34.9005 (Jun 12, 2024) |
| All-time low | $14.7373 (Nov 28, 2013) |
| 52-week high | $34.8154 |
| 52-week low | $34.7287 |
| Median price | $26.9961 |
| Average price | $26.4008 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.0%
1Y
-0.2%
3Y
+7.4%
5Y
+17.2%
All
+135.7%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cephalon, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Armodafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NUVIGIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NUVIGIL 250 MG TABLET, manufactured by Cephalon, LLC, is $34.7392 per EA (NDC 63459022530), effective Jul 1, 2026.
How has the price of NUVIGIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for NUVIGIL 250 MG TABLET has risen 135.7%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NUVIGIL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for NUVIGIL 250 MG TABLET has ranged from a low of $14.7373 (Nov 28, 2013) to a high of $34.9005 (Jun 12, 2024), with a median of $26.9961 per EA.
Are there cheaper alternatives to NUVIGIL 250 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARMODAFINIL 250 MG TABLET, is $0.8651 per EA — about 98% below NUVIGIL 250 MG TABLET.
Who manufactures NUVIGIL 250 MG TABLET?
NUVIGIL 250 MG TABLET (NDC 63459022530) is labeled by Cephalon, LLC, and CMS classifies it as a brand product.